GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.611 $0.83 Thursday, 18th Apr 2024 ATRA stock ended at $0.692. This is 3.25% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.25% from a day low at $0.690 to a day high of $0.740.
90 days $0.569 $1.58
52 weeks $0.199 $3.06

Historical Atara Biotherapeutics prices

Date Open High Low Close Volume
2023-12-29 $0.563 $0.590 $0.509 $0.513 2 547 699
2023-12-28 $0.553 $0.600 $0.549 $0.549 2 805 828
2023-12-27 $0.558 $0.575 $0.543 $0.560 3 066 302
2023-12-26 $0.550 $0.574 $0.523 $0.558 3 322 461
2023-12-22 $0.500 $0.560 $0.491 $0.542 4 930 071
2023-12-21 $0.620 $0.690 $0.443 $0.446 18 944 571
2023-12-20 $0.560 $0.613 $0.534 $0.554 1 341 739
2023-12-19 $0.550 $0.574 $0.528 $0.564 1 817 447
2023-12-18 $0.621 $0.630 $0.545 $0.573 2 332 426
2023-12-15 $0.690 $0.692 $0.600 $0.600 4 357 368
2023-12-14 $0.678 $0.690 $0.649 $0.684 2 057 950
2023-12-13 $0.634 $0.694 $0.630 $0.678 2 346 230
2023-12-12 $0.660 $0.683 $0.613 $0.650 1 947 668
2023-12-11 $0.621 $0.670 $0.621 $0.660 2 112 911
2023-12-08 $0.676 $0.695 $0.643 $0.671 1 777 495
2023-12-07 $0.700 $0.710 $0.650 $0.695 4 116 920
2023-12-06 $0.660 $0.686 $0.640 $0.660 1 555 347
2023-12-05 $0.708 $0.708 $0.630 $0.631 1 455 181
2023-12-04 $0.620 $0.717 $0.620 $0.700 2 159 517
2023-12-01 $0.646 $0.653 $0.572 $0.648 2 399 840
2023-11-30 $0.693 $0.770 $0.622 $0.660 5 133 477
2023-11-29 $0.635 $0.710 $0.628 $0.692 2 886 472
2023-11-28 $0.640 $0.650 $0.585 $0.611 2 035 192
2023-11-27 $0.690 $0.693 $0.591 $0.631 4 518 304
2023-11-24 $0.552 $0.716 $0.552 $0.652 7 907 855
Click to get the best stock tips daily for free!

About Atara Biotherapeutics

Atara Biotherapeutics Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT